The Technical Analyst
Select Language :
Avadel Pharmaceuticals [AVDL]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Avadel Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Avadel Pharmaceuticals is listed at the  Exchange

3.69% $16.84

America/New_York / 27 mar 2024 @ 16:00


Avadel Pharmaceuticals: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 1 512.65 mill
EPS: -1.960
P/E: -8.59
Earnings Date: Mar 04, 2024
SharesOutstanding: 89.83 mill
Avg Daily Volume: 1.305 mill
RATING 2024-03-27
B-
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -8.59 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.18x
Company: PE -8.59 | industry: PE 47.78
DISCOUNTED CASH FLOW VALUE
$-0.122
(-100.73%) $-16.96
Date: 2024-03-28
Expected Trading Range (DAY)

$ 15.84 - 17.84

( +/- 5.92%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-20 Kim Richard J Buy 147 000 Stock Option (Right to Buy)
2024-02-20 Mchugh Thomas S Buy 157 500 Stock Option (Right to Buy)
2024-02-20 Divis Gregory J Buy 600 000 Stock Option (Right to Buy)
2024-01-16 Mchugh Thomas S Buy 2 000 ADSs
2023-12-28 Mccamish Mark Anthony Sell 75 000 ADSs
INSIDER POWER
81.02
Last 94 transactions
Buy: 6 417 800 | Sell: 317 647

Forecast: 16:00 - $16.84

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $16.84
Forecast 2: 16:00 - $16.84
Forecast 3: 16:00 - $16.84
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $16.84 (3.69% )
Volume 0.356 mill
Avg. Vol. 1.305 mill
% of Avg. Vol 27.24 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Avadel Pharmaceuticals PLC

Last 12 Months

Last 12 months chart data with high, low, open and close for Avadel Pharmaceuticals PLC

RSI

Intraday RSI14 chart for Avadel Pharmaceuticals PLC

Last 10 Buy & Sell Signals For AVDL

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:34sell$14.80N/AActive
Profile picture for
            Avadel Pharmaceuticals PLC

AVDL

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Last 10 Buy Signals

Date Signal @
UNCXUSDMar 28 - 08:53340.04
POOLXUSDMar 28 - 08:545.36
SANTOSUSDMar 28 - 08:537.67
HBTCUSDMar 28 - 04:3931 392
DOGEUSDMar 28 - 08:55$0.216
ZENUSDMar 28 - 08:52$13.64
AVTUSDMar 28 - 08:525.70
TRIASUSDMar 28 - 08:4912.70
OKTUSDMar 28 - 08:4919.08
ROSEUSDMar 28 - 08:48$0.139

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.